Al Malki, M. M., London, K., Baez, J., Akahoshi, Y., Hogan, W. J., Etra, A., Choe, H., Hexner, E., Langston, A., Abhyankar, S., Ponce, D. M., DeFilipp, Z., Kitko, C. L., Adekola, K., Reshef, R., Ayuk, F., Capellini, A., Chanswangphuwana, C., Eder, M., … Levine, J. E. (2023). Phase 2 study of natalizumab plus standard corticosteroid treatment for high-risk acute graft-versus-host disease. Blood Advances, 7(17), 5189–5198. https://doi.org/10.1182/bloodadvances.2023009853

Pratz, K. W., Cherry, M., Altman, J. K., Cooper, B. W., Podoltsev, N. A., Cruz, J. C., Lin, T. L., Schiller, G. J., Jurcic, J. G., Asch, A., Wu, R., Hill, J. E., Gill, S. C., James, A. J., Rich, E. S., Hasabou, N., Perl, A. E., & Levis, M. J. (2023). Gilteritinib in Combination With Induction and Consolidation Chemotherapy and as Maintenance Therapy: A Phase IB Study in Patients With Newly Diagnosed AML. Journal of Clinical Oncology, 41(26), 4236–4246. https://doi.org/10.1200/jco.22.02721

Doshi, S. D., DeStephano, D., Accordino, M. K., Elkin, E., Raghunathan, R. R., Wright, J. D., & Hershman, D. L. (2023). Disparities with influenza vaccine use in long-term survivors of metastatic breast cancer. Breast Cancer Research and Treatment, 203(1), 111–119. https://doi.org/10.1007/s10549-023-07109-5

Chen, A. P., Sharon, E., O’Sullivan-Coyne, G., Moore, N., Foster, J. C., Hu, J. S., Van Tine, B. A., Conley, A. P., Read, W. L., Riedel, R. F., Burgess, M. A., Glod, J., Davis, E. J., Merriam, P., Naqash, A. R., Fino, K. K., Miller, B. L., Wilsker, D. F., Begum, A., … Doroshow, J. H. (2023). Atezolizumab for Advanced Alveolar Soft Part Sarcoma. New England Journal of Medicine, 389(10), 911–921. https://doi.org/10.1056/nejmoa2303383

Neugut, A. I., & Bates, S. E. (2023). Highlights of ASCO 2023. The Oncologist, 28(9), 739–742. https://doi.org/10.1093/oncolo/oyad222

Li, S., Fu, J., Liu, G., Ma, H., Mapara, M., Marcireau, C., & Lentzsch, S. (2023). P-200 MAP4K2 inhibition reinforces sensitivity to iberdomide in RAS-mutated MM through a CRBN-independent mechanism. Clinical Lymphoma Myeloma and Leukemia, 23, S145–S146. https://doi.org/10.1016/s2152-2650(23)01818-9

Konig, H., Tam, C. S., Lamanna, N., Jurczak, W., Kontos, A., Ruppert, A. S., & Tsai, D. E. (2023). POSTER: CT-168 Comparison of Bleeding-Related Events in Patients Who Received Pirtobrutinib With and Without Antithrombotic Agents. Clinical Lymphoma Myeloma and Leukemia, 23, S229. https://doi.org/10.1016/s2152-2650(23)00884-4

Ingham, M., Allred, J. B., Chen, L., Das, B., Kochupurakkal, B., Gano, K., George, S., Attia, S., Burgess, M. A., Seetharam, M., Boikos, S. A., Bui, N., Chen, J. L., Close, J. L., Cote, G. M., Thaker, P. H., Ivy, S. P., Bose, S., D’Andrea, A., … Schwartz, G. K. (2023). Phase II Study of Olaparib and Temozolomide for Advanced Uterine Leiomyosarcoma (NCI Protocol 10250). Journal of Clinical Oncology, 41(25), 4154–4163. https://doi.org/10.1200/jco.23.00402

Liu, Y., Mullangi, S., Debono, D., Chen, X., Pham, T., Fisch, M. J., Gordon, A. S., & Hershman, D. L. (2023). Association Between Oncology Clinical Pathway Utilization and Toxicity and Cost Outcomes in Patients With Metastatic Solid Tumors. JCO Oncology Practice, 19(9), 731–740. https://doi.org/10.1200/op.23.00199

Cytryn, S. L., Moy, R. H., Cowzer, D., Shah, R. H., Chou, J. F., Joshi, S. S., Ku, G. Y., Maron, S. B., Desai, A., Yang, J., Sugarman, R., Rao, D., Goldberg, Z., Charalambous, C., Lapshina, M., Antoine, A., Socolow, F., Trivedi, N., Capanu, M., … Janjigian, Y. Y. (2023). First-line regorafenib with nivolumab and chemotherapy in advanced oesophageal, gastric, or gastro-oesophageal junction cancer in the USA: a single-arm, single-centre, phase 2 trial. The Lancet Oncology, 24(10), 1073–1082. https://doi.org/10.1016/s1470-2045(23)00358-3

Cherng, H.-J., Capaccione, K., Ma, H., Jambawalikar, S., Orlando, E., Ford, M., Gould, P., Cuzzo, B., Lipsky, A., Pro, B., & Amengual, J. (2023). POSTER: ABCL-600 Diagnostic Utility of the 18F-FDG PET/CT Scan in EBV-Positive Solid Organ Transplant Patients at Risk for Post-Transplant Lymphoproliferative Disorder. Clinical Lymphoma Myeloma and Leukemia, 23, S203. https://doi.org/10.1016/s2152-2650(23)00722-x

Baljevic, M., Moreau, P., Tuchman, S., Callander, N., Lentzsch, S., Van Domelen, D., Bentur, O., Monge, J., & Biran, N. (2023). P-232 Effectiveness of anti-B-cell maturation antigen (BCMA)-targeting therapy after selinexor treatment. Clinical Lymphoma Myeloma and Leukemia, 23, S163. https://doi.org/10.1016/s2152-2650(23)01850-5

Fu, J., Li, S., Ma, H., Liu, G., Mapara, M., & Lentzsch, S. (2023). P-391 Checkpoint inhibitor PD-1H/VISTA mediates its effects on osteoclast cytoskeleton in myeloma bone disease via c-Src/Rac1 signaling. Clinical Lymphoma Myeloma and Leukemia, 23, S256. https://doi.org/10.1016/s2152-2650(23)02009-8

Flynn, J. R., Curry, M., Zhao, B., Yang, H., Dercle, L., Fojo, A. T., Connors, D. E., Schwartz, L. H., Gönen, M., & Moskowitz, C. S. (2023). Modeling Tumor Growth Using Partly Conditional Survival Models: A Case Study in Colorectal Cancer. JCO Clinical Cancer Informatics, 7. https://doi.org/10.1200/cci.22.00203

Alsaloum, M., Zilinyi, R. S., Madhavan, M., Snyder, D. J., Saleem, D., Burton, J. B., Rosenzweig, E. B., Takeda, K., Brodie, D., Agerstrand, C., Eisenberger, A., Kirtane, A. J., Parikh, S. A., & Sethi, S. S. (2023). Gender Disparities in Presentation, Management, and Outcomes of Acute Pulmonary Embolism. The American Journal of Cardiology, 202, 67–73. https://doi.org/10.1016/j.amjcard.2023.06.012

Hentzen, S., Meirson, T., Koehn, K., Goodman, A., Chakraborty, R., Sborov, D., Rubinstein, S., & Mohyuddin, G. R. (2023). Attrition and withdrawal in multiple myeloma randomized controlled trials: A systematic review. European Journal of Haematology, 111(3), 491–498. Portico. https://doi.org/10.1111/ejh.14032

Kumar, S., Dispenzieri, A., Bhutani, D., Gertz, M., Wechalekar, A., Palladini, G., Comenzo, R., Fonseca, R., Jaccard, A., Kastritis, E., Schönland, S., la Porte, C., Pei, H., Tran, N., & Merlini, G. (2023). Impact of cytogenetic abnormalities on treatment outcomes in patients with amyloid light-chain amyloidosis: subanalyses from the ANDROMEDA study. Amyloid, 30(3), 268–278. https://doi.org/10.1080/13506129.2022.2164488

Cherng, H.-J., Capaccione, K., Ma, H., Jambawalikar, S., Orlando, E., Ford, M., Gould, P., Cuzzo, B., Lipsky, A., Pro, B., & Amengual, J. (2023). ABCL-600 Diagnostic Utility of the 18F-FDG PET/CT Scan in EBV-Positive Solid Organ Transplant Patients at Risk for Post-Transplant Lymphoproliferative Disorder. Clinical Lymphoma Myeloma and Leukemia, 23, S442. https://doi.org/10.1016/s2152-2650(23)01337-x

Kambhampati, A., Meghani, K., Ndlovu, N., Monare, B., Mutimuri, M., Bazzett-Matabele, L., Vuylsteke, P., Ketlametswe, R., Ralefala, T., Neugut, A. I., Jacobson, J. S., Vulpe, H., & Grover, S. (2023). A Multi-Institutional Study of Barriers to Cervical Cancer Care in Sub-Saharan Africa. Advances in Radiation Oncology, 8(5), 101257. https://doi.org/10.1016/j.adro.2023.101257

Gertz, M., Abonour, R., Gibbs, S., Finkel, M., Landau, H., Lentzsch, S., Lin, G., Mahindra, A., Quock, T., Rosenbaum, C., Rosenzweig, M., Sidana, S., Tuchman, S., Witteles, R., Yermilov, I., & Broder, M. (2023). Using a Modified Delphi Panel to Estimate Health Service Utilization for Patients with Advanced and Non-Advanced Systemic Light Chain Amyloidosis. ClinicoEconomics and Outcomes Research, Volume 15, 673–680. https://doi.org/10.2147/ceor.s412079

Zhai, N., Liu, W., Jin, C.-H., Ding, Y., Sun, L., Zhang, D., Wang, Z., Tang, Y., Zhao, W., LeGuern, C., Mapara, M. Y., Wang, H., & Yang, Y.-G. (2023). Lack of IFN-γ Receptor Signaling Inhibits Graft-versus-Host Disease by Potentiating Regulatory T Cell Expansion and Conversion. The Journal of Immunology, 211(5), 885–894. https://doi.org/10.4049/jimmunol.2200411

Broustas, C. G., Mukherjee, S., Shuryak, I., Taraboletti, A., Angdisen, J., Ake, P., Fornace, A. J., & Amundson, S. A. (2023). Impact of GADD45A on Radiation Biodosimetry Using Mouse Peripheral Blood. Radiation Research, 200(3). https://doi.org/10.1667/rade-23-00052.1

Xu, B., Gordillo, C. A., Delille, E. M., Malandrakis, S., Assal, A., Mapara, M. Y., & Reshef, R. (2023). Improved serologic responses to DTaP over Tdap vaccination in adult hematopoietic cell transplant recipients. European Journal of Haematology, 111(3), 499–505. Portico. https://doi.org/10.1111/ejh.14033

Ager, C. R., Zhang, M., Chaimowitz, M., Bansal, S., Tagore, S., Obradovic, A., Jugler, C., Rogava, M., Melms, J. C., McCann, P., Spina, C., Drake, C. G., Dallos, M. C., & Izar, B. (2023). KLRG1 marks tumor-infiltrating CD4 T cell subsets associated with tumor progression and immunotherapy response. Journal for ImmunoTherapy of Cancer, 11(9), e006782. https://doi.org/10.1136/jitc-2023-006782

Akpan, I. J., & Hunt, B. J. (2023). How I approach the prevention and treatment of thrombotic complications in hospitalized patients. Blood, 142(9), 769–776. https://doi.org/10.1182/blood.2021014835

Kalinsky, K., Accordino, M. K., Chiuzan, C., Mundi, P. S., Sakach, E., Sathe, C., Ahn, H., Trivedi, M. S., Novik, Y., Tiersten, A., Raptis, G., Baer, L. N., Oh, S. Y., Zelnak, A. B., Wisinski, K. B., Andreopoulou, E., Gradishar, W. J., Stringer-Reasor, E., Reid, S. A., … Hershman, D. L. (2023). Randomized Phase II Trial of Endocrine Therapy With or Without Ribociclib After Progression on Cyclin-Dependent Kinase 4/6 Inhibition in Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer: MAINTAIN Trial. Journal of Clinical Oncology, 41(24), 4004–4013. https://doi.org/10.1200/jco.22.02392

Koerner, A. S., Moy, R. H., Ryeom, S. W., & Yoon, S. S. (2023). The Present and Future of Neoadjuvant and Adjuvant Therapy for Locally Advanced Gastric Cancer. Cancers, 15(16), 4114. https://doi.org/10.3390/cancers15164114

Koch, P. A., Paul, R., Contento, I. R., Gray, H. L., Marín-Chollom, A. M., Santiago-Torres, M., Shen, H., Jones, S. M. W., Hershman, D. L., & Greenlee, H. (2023). Mi Vida Saludable: Content Validity and Reliability of The Preferences and Self-Efficacy of Diet and Physical Activity Behaviors Questionnaire for Latina Women (PSEDPALW) for Cancer Survivors. Nutrients, 15(16), 3563. https://doi.org/10.3390/nu15163563

Chakraborty, R., Al Hadidi, S., Scheffer Cliff, E. R., & Mohyuddin, G. R. (2023). Is aggressive treatment of smoldering myeloma the path to curing myeloma? Blood Advances, 7(15), 3932–3935. https://doi.org/10.1182/bloodadvances.2023009658

Jiang, Z., Wu, F., Laise, P., Takayuki, T., Na, F., Kim, W., Kobayashi, H., Chang, W., Takahashi, R., Valenti, G., Sunagawa, M., White, R. A., Macchini, M., Renz, B. W., Middelhoff, M., Hayakawa, Y., Dubeykovskaya, Z. A., Tan, X., Chu, T. H., … Wang, T. C. (2023). Tff2 defines transit-amplifying pancreatic acinar progenitors that lack regenerative potential and are protective against Kras-driven carcinogenesis. Cell Stem Cell, 30(8), 1091-1109.e7. https://doi.org/10.1016/j.stem.2023.07.002

Wright, J. D., Chen, L., Suzuki, Y., Matsuo, K., & Hershman, D. L. (2023). National Estimates of Gender-Affirming Surgery in the US. JAMA Network Open, 6(8), e2330348. https://doi.org/10.1001/jamanetworkopen.2023.30348

Phakathi, B., Dix-Peek, T., Van Den Berg, E., Dickens, C., Nietz, S., Cubasch, H., Joffe, M., Neugut, A. I., Jacobson, J. S., Ruff, P., & Duarte, R. (2023). PAM50 intrinsic subtypes, risk of recurrence score and breast cancer survival in HIV-positive and HIV-negative patients—a South African cohort study. Breast Cancer Research and Treatment, 200(3), 337–346. https://doi.org/10.1007/s10549-023-06969-1

Kao, D. D., Ferrandino, R. M., Roof, S. A., Marshall, D. C., Khan, M. N., Chai, R. L., Park, Y. A., & Sigel, K. M. (2023). Neutrophil‐to‐lymphocyte ratio as a predictor of surgical outcomes in head and neck cancer. Head & Neck, 45(8), 1903–1912. Portico. https://doi.org/10.1002/hed.27402

Ali, M. O., Abdullah, H. M., Obeidat, K., Chakraborty, R., & Al Hadidi, S. (2023). Follow up duration of phase III Multiple Myeloma Clinical Trials: A systematic review. EJHaem, 4(3), 719–722. Portico. https://doi.org/10.1002/jha2.680

Kulkarni, A., Chen, L., Gockley, A., Khoury-Collado, F., Hou, J., Clair, C. S. T., Melamed, A., Hershman, D. L., & Wright, J. D. (2023). Patterns of cervical cancer screening follow-up in the era of prolonged screening intervals. Gynecologic Oncology, 175, 53–59. https://doi.org/10.1016/j.ygyno.2023.06.007

Kiryluk, K., Freedberg, D. E., Radhakrishnan, J., Segall, L., Jacobson, J. S., Mathur, M., Mohan, S., & Neugut, A. I. (2023). Global Incidence of IgA Nephropathy by Race and Ethnicity: A Systematic Review. Kidney360, 4(8), 1112–1122. https://doi.org/10.34067/kid.0000000000000165

Mehta-Shah, N., Jacobsen, E., Luigi Zinzani, P., Zain, J., Mead, M., Casulo, C., Gritti, G., Pinter-Brown, L., Izutsu, K., Waters, S., Brammer, J., Pro, B., & Horwitz, S. (2023). P1124: DUVELISIB IN PATIENTS WITH RELAPSED/REFRACTORY PERIPHERAL T-CELL LYMPHOMA FROM THE PHASE 2 PRIMO TRIAL EXPANSION PHASE: OUTCOMES BY BASELINE HISTOLOGY. HemaSphere, 7(S3), e3891642. https://doi.org/10.1097/01.hs9.0000971392.38916.42

Li, J., Hubisz, M. J., Earlie, E. M., Duran, M. A., Hong, C., Varela, A. A., Lettera, E., Deyell, M., Tavora, B., Havel, J. J., Phyu, S. M., Amin, A. D., Budre, K., Kamiya, E., Cavallo, J.-A., Garris, C., Powell, S., Reis-Filho, J. S., Wen, H., … Bakhoum, S. F. (2023). Non-cell-autonomous cancer progression from chromosomal instability. Nature, 620(7976), 1080–1088. https://doi.org/10.1038/s41586-023-06464-z

Rillamas-Sun, E., Kwan, M. L., Iribarren, C., Cheng, R., Neugebauer, R., Rana, J. S., Nguyen-Huynh, M., Shi, Z., Laurent, C. A., Lee, V. S., Roh, J. M., Huang, Y., Shen, H., Hershman, D. L., Kushi, L. H., & Greenlee, H. (2023). Development of cardiometabolic risk factors following endocrine therapy in women with breast cancer. Breast Cancer Research and Treatment, 201(1), 117–126. https://doi.org/10.1007/s10549-023-06997-x

Moodley, Y., van Wyk, J., Ning, Y., Wexner, S., Gounden, C., Naidoo, V., Kader, S., Neugut, A. I., & Kiran, R. P. (2023). Self-adherence to post-colonoscopy consults in patients undergoing diagnostic colonoscopy: Findings from a cross-sectional, quantitative survey at a South African quaternary hospital. PLOS ONE, 18(7), e0288752. https://doi.org/10.1371/journal.pone.0288752

Hagkarim, N. C., Hajkarim, M. C., Suzuki, T., Fujiwara, T., Winkler, G. S., Stewart, G. S., & Grand, R. J. (2023). Disruption of the Mammalian Ccr4–Not Complex Contributes to Transcription-Mediated Genome Instability. Cells, 12(14), 1868. https://doi.org/10.3390/cells12141868

Ijaz, N., Hassan, A., Ghannoum, S., Choudhury, T., & Piracha, N. (2023). Assessment of health-care workers’ attitudes, knowledge, and skills in the care of critically ill Muslim children in New York. Palliative and Supportive Care, 1–6. https://doi.org/10.1017/s1478951523001049

Gladstone, D. E., D’Alessio, F., Howard, C., Lyu, M.-A., Mock, J. R., Gibbs, K. W., Abrams, D., Huang, M., Zeng, K., Herlihy, J. P., Castillo, S. T., Bassett, R., Sadeghi, T., Parmar, S., Flowers, C. R., Mukherjee, S., Schoenfeld, D., Thall, P. F., & Slutsky, A. S. (2023). Randomized, double-blinded, placebo-controlled trial of allogeneic cord blood T-regulatory cells for treatment of COVID-19 ARDS. Blood Advances, 7(13), 3075–3079. https://doi.org/10.1182/bloodadvances.2022009619

de Botton, S., Fenaux, P., Yee, K., Récher, C., Wei, A. H., Montesinos, P., Taussig, D. C., Pigneux, A., Braun, T., Curti, A., Grove, C., Jonas, B. A., Khwaja, A., Legrand, O., Peterlin, P., Arnan, M., Blum, W., Cilloni, D., Hiwase, D. K., … Cortes, J. (2023). Olutasidenib (FT-2102) induces durable complete remissions in patients with relapsed or refractory IDH1-mutated AML. Blood Advances, 7(13), 3117–3127. https://doi.org/10.1182/bloodadvances.2022009411

Ho, P., Melms, J. C., Rogava, M., Frangieh, C. J., Poźniak, J., Shah, S. B., Walsh, Z., Kyrysyuk, O., Amin, A. D., Caprio, L., Fullerton, B. T., Soni, R. K., Ager, C. R., Biermann, J., Wang, Y., Khosravi-Maharlooei, M., Zanetti, G., Mu, M., Fatima, H., … Izar, B. (2023). The CD58-CD2 axis is co-regulated with PD-L1 via CMTM6 and shapes anti-tumor immunity. Cancer Cell, 41(7), 1207-1221.e12. https://doi.org/10.1016/j.ccell.2023.05.014

Mato, A. R., Woyach, J. A., Brown, J. R., Ghia, P., Patel, K., Eyre, T. A., Munir, T., Lech-Maranda, E., Lamanna, N., Tam, C. S., Shah, N. N., Coombs, C. C., Ujjani, C. S., Fakhri, B., Cheah, C. Y., Patel, M. R., Alencar, A. J., Cohen, J. B., Gerson, J. N., … Jurczak, W. (2023). Pirtobrutinib after a Covalent BTK Inhibitor in Chronic Lymphocytic Leukemia. New England Journal of Medicine, 389(1), 33–44. https://doi.org/10.1056/nejmoa2300696

Madan, R. A., Bilusic, M., Stein, M. N., Donahue, R. N., Arlen, P. M., Karzai, F., Plimack, E., Wong, Y.-N., Geynisman, D. M., Zibelman, M., Mayer, T., Strauss, J., Chen, G., Rauckhorst, M., McMahon, S., Couvillon, A., Steinberg, S., Figg, W. D., Dahut, W. L., … Gulley, J. L. (2023). Flutamide With or Without PROSTVAC in Non-metastatic Castration Resistant (M0) Prostate Cancer. The Oncologist, 28(7), 642-e561. https://doi.org/10.1093/oncolo/oyad058

Long, J., Soni, M., Muranski, P., Miller, M. J., Conry-Cantilena, C., & De Giorgi, V. (2023). Case Report: Kinetics and durability of humoral and cellular response of SARS-CoV-2 messenger RNA vaccine in a lung and kidney transplant recipient. Frontiers in Immunology, 14. https://doi.org/10.3389/fimmu.2023.1207638

Wu, A., McWatt, S. C., Utomo, R., Talis, A., Xiao, Q. Y., Saraci, K., Brassett, C., Sagoo, M. G., Wingate, R., Chien, C., Traxler, H., Waschke, J., Vielmuth, F., Sigmund, A., Yamada, Y., Sakurai, T., Zeroual, M., Olsen, J., El‐Batti, S., … Noël, G. P. J. C. (2023). A thematic analysis of students’ discussions on death and body donation in international online focus groups. Anatomical Sciences Education, 16(4), 768–784. Portico. https://doi.org/10.1002/ase.2265

Oberlin, A., Krenitsky, N. M., Gandhi, C., Akpan, I. J., Eisenberger, A., Landau, R., Yurteri-Kaplan, L., Nathan, L., Sheen, J.-J., LaSala, A., & D’Alton, M. (2023). Acquired Hemophilia A: A Rare, Acquired Coagulopathy in the Postpartum Setting. American Journal of Perinatology Reports, 13(04), e85–e88. CLOCKSS. https://doi.org/10.1055/a-2198-7888